A Phase III, partially modified double-blind, randomized, parallel-group, active-controlled, multi-center study to compare the immunogenicity and describe the safety of MenACYW conjugate vaccine and MENVEO? when administered concomitantly with routine pe

Project: Other project

StatusActive
Effective start/end date5/2/185/1/20

Funding

  • Sanofi Pasteur Inc: $10,861.53